BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28858372)

  • 1. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?
    Chen AB; Li L; Cronin AM; Brooks GA; Kavanagh BD; Schrag D
    Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):3227-3244. PubMed ID: 28858372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of trends in the cost of initial cancer treatment.
    Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
    J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?
    Yabroff KR; Warren JL; Banthin J; Schrag D; Mariotto A; Lawrence W; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S64-9. PubMed ID: 19536016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Area-level variations in cancer care and outcomes.
    Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
    Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.
    Chen CT; Li L; Brooks G; Hassett M; Schrag D
    Health Serv Res; 2018 Aug; 53(4):2118-2132. PubMed ID: 28748564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
    Sagar B; Lin YS; Castel LD
    J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast Cancer.
    Xu X; Herrin J; Soulos PR; Saraf A; Roberts KB; Killelea BK; Wang SY; Long JB; Wang R; Ma X; Gross CP
    Health Serv Res; 2016 Feb; 51(1):167-86. PubMed ID: 26119176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Quality of Comorbid Condition Care and Costs for Cancer Survivors.
    Frick KD; Snyder CF; Herbert RJ; Blackford AL; Neville BA; Wolff AC; Carducci MA; Earle CC
    J Oncol Pract; 2016 Jun; 12(6):e734-45. PubMed ID: 27165487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out-of-pocket medical expenses compared across five years for patients with one of five common cancers in Australia.
    Rodriguez-Acevedo AJ; Chan RJ; Olsen CM; Pandeya N; Whiteman DC; Gordon LG
    BMC Cancer; 2021 Sep; 21(1):1055. PubMed ID: 34563142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the cost of cancer care in the United States: a work very much in progress.
    Lipscomb J
    J Natl Cancer Inst; 2008 May; 100(9):607-10. PubMed ID: 18445816
    [No Abstract]   [Full Text] [Related]  

  • 13. Projections of the cost of cancer care in the United States: 2010-2020.
    Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
    J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Medicare data to estimate the number of cases missed by a cancer registry: a 3-source capture-recapture model.
    McClish D; Penberthy L
    Med Care; 2004 Nov; 42(11):1111-6. PubMed ID: 15586838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
    Etzioni R; Ramsey SD; Berry K; Brown M
    Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-Attributable Medical Costs for Colorectal Cancer Patients by Phases of Care: What Is the Effect of a Prior Cancer History?
    Mariotto AB; Warren JL; Zeruto C; Coughlan D; Barrett MJ; Zhao L; Yabroff KR
    J Natl Cancer Inst Monogr; 2020 May; 2020(55):22-30. PubMed ID: 32412066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional variation in spending and survival for older adults with advanced cancer.
    Brooks GA; Li L; Sharma DB; Weeks JC; Hassett MJ; Yabroff KR; Schrag D
    J Natl Cancer Inst; 2013 May; 105(9):634-42. PubMed ID: 23482657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.
    Klabunde CN; Legler JM; Warren JL; Baldwin LM; Schrag D
    Ann Epidemiol; 2007 Aug; 17(8):584-90. PubMed ID: 17531502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient time costs associated with cancer care.
    Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
    J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in treatment costs for localized prostate cancer: the healthy screenee effect.
    Zeliadt SB; Etzioni R; Ramsey SD; Penson DF; Potosky AL
    Med Care; 2007 Feb; 45(2):154-9. PubMed ID: 17224778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.